Korro Bio

Risk score

57

Headquarters

Flag of United States of AmericaUnited States of America

KORRO BIO focuses on developing revolutionary therapeutics for patients through the selective modification of messenger RNA to alter specific codons, resulting in a positive transformation of protein sequence, structure, and function.